{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T17:43:24Z","timestamp":1786211004758,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,8]]},"DOI":"10.7759\/cureus.114173","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T17:04:17Z","timestamp":1786208657000},"source":"Crossref","is-referenced-by-count":0,"title":["Ganglioside Antibodies as Formidable Neurologic Mimickers: A Case Report of Dual Anti-GQ1b and Asialo-GM1 Antibody Syndrome"],"prefix":"10.7759","author":[{"given":"Emily","family":"Ahner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Haikal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sannah","family":"Vasaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroucha","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0388-9","article-title":"Physiology of gangliosides and the role of antiganglioside antibodies in human diseases","volume":"17","author":"Cutillo G","year":"2020","unstructured":"Cutillo G, Saariaho AH, Meri S. Physiology of gangliosides and the role of antiganglioside antibodies in human diseases. Cell Mol Immunol. 2020, 17:313-22. 10.1038\/s41423-020-0388-9","journal-title":"Cell Mol Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-022-01940-1","article-title":"Clinical and antibodies analysis of anti-GQ1b antibody syndrome: a case series of 15 patients","volume":"123","author":"Wu X","year":"2023","unstructured":"Wu X, Wang Y, Xi ZQ. Clinical and antibodies analysis of anti-GQ1b antibody syndrome: a case series of 15 patients. Acta Neurol Belg. 2023, 123:839-47. 10.1007\/s13760-022-01940-1","journal-title":"Acta Neurol Belg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-302824","article-title":"Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome","volume":"84","author":"Shahrizaila N","year":"2013","unstructured":"Shahrizaila N, Yuki N. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry. 2013, 84:576-83. 10.1136\/jnnp-2012-302824","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2008.03.001","article-title":"Recurrent facial nerve palsy associated with anti-GQ1b IgG antibodies","volume":"30","author":"Greco F","year":"2008","unstructured":"Greco F, Barbagallo ML, Guglielmino R, Sorge G. Recurrent facial nerve palsy associated with anti-GQ1b IgG antibodies. Brain Dev. 2008, 30:606-8. 10.1016\/j.braindev.2008.03.001","journal-title":"Brain Dev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg233","article-title":"Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barr\u00e9 syndrome","volume":"126","author":"Odaka M","year":"2003","unstructured":"Odaka M, Yuki N, Yamada M, Koga M, Takemi T, Hirata K, Kuwabara S. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barr\u00e9 syndrome. Brain. 2003, 126:2279-90. 10.1093\/brain\/awg233","journal-title":"Brain"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2005.11.005","article-title":"A new type of anti-ganglioside antibodies present in neurological patients","volume":"1762","author":"Lopez PH","year":"2006","unstructured":"Lopez PH, Com\u00edn R, Villa AM, Di Egidio M, Saizar RD, Sica RE, Nores GA. A new type of anti-ganglioside antibodies present in neurological patients. Biochim Biophys Acta. 2006, 1762:357-61. 10.1016\/j.bbadis.2005.11.005","journal-title":"Biochim Biophys Acta"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07686-3","article-title":"The spectrum of anti-GQ1B antibody syndrome: beyond Miller Fisher syndrome and Bickerstaff brainstem encephalitis","volume":"45","author":"Noioso CM","year":"2024","unstructured":"Noioso CM, Bevilacqua L, Acerra GM, et al.. The spectrum of anti-GQ1B antibody syndrome: beyond Miller Fisher syndrome and Bickerstaff brainstem encephalitis. Neurol Sci. 2024, 45:5657-69. 10.1007\/s10072-024-07686-3","journal-title":"Neurol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00580-4","article-title":"Guillain-Barr\u00e9 syndrome","volume":"10","author":"Leonhard SE","year":"2024","unstructured":"Leonhard SE, Papri N, Querol L, Rinaldi S, Shahrizaila N, Jacobs BC. Guillain-Barr\u00e9 syndrome. Nat Rev Dis Primers. 2024, 10:97. 10.1038\/s41572-024-00580-4","journal-title":"Nat Rev Dis Primers"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2013.01.057","article-title":"Multifocal motor neuropathy","volume":"42","author":"Guimar\u00e3es-Costa R","year":"2013","unstructured":"Guimar\u00e3es-Costa R, Bombelli F, L\u00e9ger JM. Multifocal motor neuropathy. Presse Med. 2013, 42:e217-24. 10.1016\/j.lpm.2013.01.057","journal-title":"Presse Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/019459988509300202","article-title":"Facial nerve grading system","volume":"93","author":"House JW","year":"1985","unstructured":"House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985, 93:146-7. 10.1177\/019459988509300202","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001942.pub5","article-title":"Corticosteroids for Bell's palsy (idiopathic facial paralysis)","volume":"7","author":"Madhok VB","year":"2016","unstructured":"Madhok VB, Gagyor I, Daly F, Somasundara D, Sullivan M, Gammie F, Sullivan F. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2016, 7:CD001942. 10.1002\/14651858.CD001942.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001446.pub5","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","volume":"10","author":"Hughes RA","year":"2016","unstructured":"Hughes RA, Brassington R, Gunn AA, van Doorn PA. Corticosteroids for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2016, 10:CD001446. 10.1002\/14651858.CD001446.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.40.7.1067","article-title":"The spectrum of neurologic disease associated with anti-GM1 antibodies","volume":"40","author":"Sadiq SA","year":"1990","unstructured":"Sadiq SA, Thomas FP, Kilidireas K, et al.. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology. 1990, 40:1067-72. 10.1212\/wnl.40.7.1067","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002063.pub6","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Hughes RA","year":"2014","unstructured":"Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2014, 2014:CD002063. 10.1002\/14651858.CD002063.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01108-4","article-title":"Update on intravenous immunoglobulin in neurology: modulating neuro-autoimmunity, evolving factors on efficacy and dosing and challenges on stopping chronic IVIG therapy","volume":"18","author":"Dalakas MC","year":"2021","unstructured":"Dalakas MC. Update on intravenous immunoglobulin in neurology: modulating neuro-autoimmunity, evolving factors on efficacy and dosing and challenges on stopping chronic IVIG therapy. Neurotherapeutics. 2021, 18:2397-418. 10.1007\/s13311-021-01108-4","journal-title":"Neurotherapeutics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/510647-ganglioside-antibodies-as-formidable-neurologic-mimickers-a-case-report-of-dual-anti-gq1b-and-asialo-gm1-antibody-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T17:04:20Z","timestamp":1786208660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/510647-ganglioside-antibodies-as-formidable-neurologic-mimickers-a-case-report-of-dual-anti-gq1b-and-asialo-gm1-antibody-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.114173","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,8]]}}}